Nichols, Robert J.
Haderk, Franziska
Stahlhut, Carlos
Schulze, Christopher J.
Hemmati, Golzar
Wildes, David
Tzitzilonis, Christos
Mordec, Kasia
Marquez, Abby
Romero, Jason
Hsieh, Tientien
Zaman, Aubhishek
Olivas, Victor
McCoach, Caroline
Blakely, Collin M.
Wang, Zhengping
Kiss, Gert
Koltun, Elena S.
Gill, Adrian L.
Singh, Mallika
Goldsmith, Mark A.
Smith, Jacqueline A. M. http://orcid.org/0000-0001-5028-8725
Bivona, Trever G. http://orcid.org/0000-0001-5734-4128
Article History
Received: 2 June 2018
Accepted: 16 July 2018
First Online: 13 August 2018
Competing interests
: T.G.B. is a consultant to Novartis, AstraZeneca, Array Biopharma (Scientific Advisory Board) and Inventiva, and is the recipient of research grants from Ignyta and Revolution Medicines. T.G.B. is a member of the Revolution Medicines Scientific Advisory Board. R.J.N., C.S., C.J.S., D.W., C.T., K.M., A.M., J.R., T.H., Z.W., G.K., E.S.K., A.L.G., M.S., M.A.G. and J.A.M.S. are employees of Revolution Medicines, Inc. Revolution Medicines holds the patent mentioned in the Methods section. The other authors declare no competing interests.